or Try an Advanced Search...

    Technical Analysis for GTG - Genetic Technologies Limited

    Grade Last Price % Change Price Change
    D 0.039 0.00% 0.000
    GTG closed up 2.63 percent on Wednesday, October 16, 2024, on 16 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical GTG trend table...
    Date Alert Name Type % Chg
    Bollinger Band Squeeze Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Stochastic Reached Oversold Weakness 0.00%
    Gapped Up Strength 0.00%
    Oversold Stochastic Weakness 0.00%
    Bollinger Band Squeeze Range Contraction 2.63%
    Narrow Range Bar Range Contraction 2.63%
    Fell Below 20 DMA Bearish 0.00%
    Volume Surge Other 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    Older End-of-Day Signals for GTG ...

       Recent Intraday Alerts

    Alert Time
    No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock.
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    GTG Chart by TradingView
    Basic chart:

    Profile

    Genetic Technologies Limited Description

    Genetic Technologies Limited is a molecular diagnostics company. The Company is engaged in the provision of molecular risk assessment for cancer. The Company offers predictive testing and assessment tools for physicians to manage women's health. The Company's lead product, BREVAGenplus, is a clinically validated risk assessment test for non-hereditary breast cancer. The Company markets BREVAGenplus to healthcare professionals in breast healthcare and imaging centers, as well as to obstetricians/gynecologists (OBGYNs) and breast cancer risk assessment specialists, such as breast surgeons. The Company operates in Australia, the United States and Switzerland. The Company's subsidiaries include Genetic Technologies Corporation Pty. Ltd. and Phenogen Sciences Inc. Genetic Technologies Corporation Pty. Ltd. is engaged in genetic testing. The Company has launched the BREVAGen test across the United States through Phenogen Sciences Inc.

    Classification
    Sector: Healthcare
    Industry: Diagnostics & Research
    Keywords: Health Healthcare Medicine Biotechnology Cancer Imaging Clinical Medicine Breast Cancer Medical Tests Healthcare Professionals Molecular Diagnostics Medical Genetics

    Is GTG a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 11 BioVie and Genetic Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
    Sep 23 Join Genetic Technology’s Exclusive Live Investor Webinar and Q&A Session on October 2
    Sep 11 Genetic Technologies Invited to Join Prestigious “CancerIQ” Online Platform - Provides Access to 45 Healthcare Systems and 250 Clinics
    Aug 31 Genetic Technologies Full Year 2024 Earnings: AU$0.001 loss per share (vs AU$0.12 loss in FY 2023)
    Aug 15 Genetic Technologies Insider Purchases Yet To Pay Off Regardless Of Recent Strength
    Aug 15 Genetic Technologies Announces Global Launch of geneType™ on Wholly Owned EasyDNA platform
    Aug 9 Join Genetic Technology’s Exclusive Live Investor Webinar and Q&A Session on August 15
    Jul 26 Genetic Technologies Strategic Restructure Driving USA Sales Growth
    Jul 16 Genetic Technologies Announces Appointment of Chief Financial Officer & Company Secretary
    Jul 9 GeneType to Enter Canadian and New Zealand Markets
    See more GTG news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 0.2
    52 Week Low 0.002
    Average Volume 63,740
    200-Day Moving Average 0.095
    50-Day Moving Average 0.041
    20-Day Moving Average 0.040
    10-Day Moving Average 0.040
    Average True Range 0.002
    RSI (14) 49.24
    ADX 18.17
    +DI 23.298
    -DI 21.147
    Chandelier Exit (Long, 3 ATRs) 0.037
    Chandelier Exit (Short, 3 ATRs) 0.044
    Upper Bollinger Bands 0.042
    Lower Bollinger Band 0.038
    Percent B (%b) 0.32
    BandWidth 11.055
    MACD Line -0.001
    MACD Signal Line -0.001
    MACD Histogram 0.0002
    Fundamentals Value
    Market Cap 322.21 Million
    Num Shares 8.26 Billion
    EPS 0.00
    Price-to-Earnings (P/E) Ratio -19.50
    Price-to-Sales 2948.61
    Price-to-Book 4.44
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.039
    Resistance 3 (R3) 0.039 0.039 0.039
    Resistance 2 (R2) 0.039 0.039 0.039 0.039
    Resistance 1 (R1) 0.039 0.039 0.039 0.039 0.039
    Pivot Point 0.039 0.039 0.039 0.039 0.039
    Support 1 (S1) 0.039 0.039 0.039 0.039 0.039
    Support 2 (S2) 0.039 0.039 0.039 0.039
    Support 3 (S3) 0.039 0.039 0.039
    Support 4 (S4) 0.039